Mizuho Reiterates Buy on Hologic, Maintains $95 Price Target
Portfolio Pulse from richadhand@benzinga.com
Mizuho analyst Anthony Petrone reiterates a Buy rating on Hologic (NASDAQ:HOLX) and maintains a $95 price target.
June 15, 2023 | 12:58 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Mizuho analyst Anthony Petrone reiterates a Buy rating on Hologic and maintains a $95 price target.
The news directly mentions Hologic (NASDAQ:HOLX) and the analyst's Buy rating and $95 price target. This reaffirmation of the Buy rating by a reputable analyst is likely to have a positive short-term impact on the stock price, as it signals confidence in the company's performance and potential growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100